Drusen Clinical Trial
Official title:
The Affiliated Eye Hospital of Wenzhou Medical University
To investigate the efficacy and safety of sub-threshold micro-pulse laser therapy for drusen of dry age-related macular degeneration (AMD) .
Status | Recruiting |
Enrollment | 20 |
Est. completion date | April 30, 2022 |
Est. primary completion date | April 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: 1. Older than 50 years of age. 2. Male or female patients with nonexudative AMD with a drusen diameter of at least 125um in the central 3mm circle 3. clear media to perform colour, red-free imaging and fundus fluorescein angiography, fundus autofluorescence imaging and OCT. 4. Able to give an informed consent. Exclusion Criteria: 1. Presence of other macular disease such as epiretinal membrane, macular telangiectasia. 2. unclear media that no clear colour, red-free imaging and fundus fluorescein angiography, fundus autofluorescence imaging and OCT can performed. 3. Ocular or periocular infections. |
Country | Name | City | State |
---|---|---|---|
China | The eye of Wenzhou Medical University | Wenzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
The Eye Hospital of Wenzhou Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in macular drusen volume | Mean change in macular drusen volume on optical coherence tomograph(OCT) | 6 and 12 months | |
Primary | Change in macular drusen area | Mean change in macular drusen area on OCT | 6 and 12 months | |
Secondary | Change in visual acuity | Mean change in best-corrected visual acuity | 6 and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A |